Literature DB >> 25957792

The accumulation of brain water-free sodium is associated with ischemic damage independent of the blood pressure in female rats.

Manabu Sumiyoshi1, Keiko T Kitazato2, Kenji Yagi2, Takeshi Miyamoto2, Yoshitaka Kurashiki2, Nobuhisa Matsushita2, Tomoya Kinouchi2, Kazuyuki Kuwayama2, Junichiro Satomi2, Shinji Nagahiro2.   

Abstract

Estrogen deficiency worsens ischemic stroke outcomes. In ovariectomized (OVX(+)) rats fed a high-salt diet (HSD), an increase in the body Na(+)/water ratio, which characterizes water-free Na(+) accumulation, was associated with detrimental vascular effects independent of the blood pressure (BP). We hypothesized that an increase in brain water-free Na(+) accumulation is associated with ischemic brain damage in OVX(+)/HSD rats. To test our hypothesis we divided female Wistar rats into 4 groups, OVX(+) and OVX(-) rats fed HSD or a normal diet (ND), and subjected them to transient cerebral ischemia. The brain Na(+)/water ratio was increased even in OVX(+)/ND rats and augmented in OVX(+)/HSD rats. The increase in the brain Na(+)/water ratio was positively correlated with expansion of the cortical infarct volume without affecting the BP. Interestingly, OVX(+) was associated with the decreased expression of ATP1α3, a subtype of the Na(+) efflux pump. HSD increased the expression of brain Na(+) influx-related molecules and the mineralocorticoid receptor (MR). The pretreatment of OVX(+)/HSD rats with the MR antagonist eplerenone reduced brain water-free Na(+) accumulation, up-regulated ATP1α3, down-regulated MR, and reduced the cortical infarct volume. Our findings show that the increase in the brain Na(+)/water ratio elicited by estrogen deficiency or HSD is associated with ischemic brain damage BP-independently, suggesting the importance of regulating the accumulation of brain water-free Na(+). The up-regulation of ATP1α3 and the down-regulation of MR may provide a promising therapeutic strategy to attenuate ischemic brain damage in postmenopausal women.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain water-free sodium accumulation; Cerebral ischemia; High-salt intake; Hypertension; Mineralocorticoid receptor; Na(+)/K(+)-ATPase; Ovariectomy

Mesh:

Substances:

Year:  2015        PMID: 25957792     DOI: 10.1016/j.brainres.2015.04.051

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  High salt-induced activation and expression of inflammatory cytokines in cultured astrocytes.

Authors:  Zhezhi Deng; Yuge Wang; Li Zhou; Yilong Shan; Sha Tan; Wei Cai; Siyuan Liao; Lisheng Peng; Zhengqi Lu
Journal:  Cell Cycle       Date:  2017-03-15       Impact factor: 4.534

2.  An imbalance between RAGE/MR/HMGB1 and ATP1α3 is associated with inflammatory changes in rat brain harboring cerebral aneurysms prone to rupture.

Authors:  Eiji Shikata; Takeshi Miyamoto; Tadashi Yamaguchi; Izumi Yamaguchi; Hiroshi Kagusa; Daiki Gotoh; Kenji Shimada; Yoshiteru Tada; Kenji Yagi; Keiko T Kitazato; Yasuhisa Kanematsu; Yasushi Takagi
Journal:  J Neuroinflammation       Date:  2022-06-20       Impact factor: 9.587

3.  Ellagic acid improves electrocardiogram waves and blood pressure against global cerebral ischemia rat experimental models.

Authors:  Khojasteh Hoseiny Nejad; Mahin Dianat; Alireza Sarkaki; Mohammad Kazem Gharib Naseri; Mohammad Badavi; Yaghoub Farbood
Journal:  Electron Physician       Date:  2015-08-10

4.  Astrocyte-derived VEGF increases cerebral microvascular permeability under high salt conditions.

Authors:  Zhezhi Deng; Li Zhou; Yuge Wang; Siyuan Liao; Yinong Huang; Yilong Shan; Sha Tan; Qin Zeng; Lisheng Peng; Haiwei Huang; Zhengqi Lu
Journal:  Aging (Albany NY)       Date:  2020-06-22       Impact factor: 5.682

Review 5.  The modulatory effect of high salt on immune cells and related diseases.

Authors:  Xian Li; Aqu Alu; Yuquan Wei; Xiawei Wei; Min Luo
Journal:  Cell Prolif       Date:  2022-06-23       Impact factor: 8.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.